📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Mexiletine (NaMuscla) for the treatment of myotonia in non-dystrophic myotonic disorders (2020)

First Author: Suetterlin K

Attributed to: Progressive Muscular Weakness in Periodic Paralysis and Normal Ageing funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/21678707.2020.1739519

Publication URI: http://dx.doi.org/10.1080/21678707.2020.1739519

Type: Journal Article/Review

Parent Publication: Expert Opinion on Orphan Drugs

Issue: 2-3